Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0J8DC
|
||||
| Former ID |
DNC006806
|
||||
| Drug Name |
1-(2-(naphthalen-1-yl)-1-phenylethyl)piperazine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C22H24N2
|
||||
| Canonical SMILES |
C1CN(CCN1)C(CC2=CC=CC3=CC=CC=C32)C4=CC=CC=C4
|
||||
| InChI |
1S/C22H24N2/c1-2-8-19(9-3-1)22(24-15-13-23-14-16-24)17-20-11-6-10-18-7-4-5-12-21(18)20/h1-12,22-23H,13-17H2
|
||||
| InChIKey |
VWOWSEBOGHLBFX-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Sodium-dependent serotonin transporter | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Serotonergic synapse | ||||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | 5HT1 type receptor mediated signaling pathway | ||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| WikiPathways | Monoamine Transport | ||||
| SIDS Susceptibility Pathways | |||||
| NRF2 pathway | |||||
| Synaptic Vesicle Pathway | |||||
| Serotonin Transporter Activity | |||||
| References | |||||
| REF 1 | Bioorg Med Chem Lett. 2006 Aug 15;16(16):4349-53. Epub 2006 Jun 5.Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.